免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

iSage Rx(iSage Rx 基础胰岛素滴定)

K号: K161865 · 2017-03-07

申请人Isag Rx, Inc.
决定日期2017-03-07
产品代码NDC
咨询委员会AN 请注意,由于您没有提供完整的医疗设备监管文本,我无法提供完整的翻译。如果您能提供完整的文本,我将很乐意为您翻译。
决定实质等同

器械摘要

iSage Rx (iSage Rx Basal Insulin Titration) is the device name listed in this FDA 510(k) record. The listed applicant is Isag Rx, Inc.. It received FDA 510(k) clearance on 2017-03-07 under 510(k) number K161865. The device is classified under product code NDC. It was reviewed by the AN advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the iSage Rx (iSage Rx Basal Insulin Titration)?

iSage Rx (iSage Rx Basal Insulin Titration) is a medical device that received FDA 510(k) clearance on 2017-03-07. The listed applicant is Isag Rx, Inc.. The 510(k) number is K161865.

When did iSage Rx (iSage Rx Basal Insulin Titration) receive FDA 510(k) clearance?

iSage Rx (iSage Rx Basal Insulin Titration) received FDA 510(k) clearance on 2017-03-07, under 510(k) number K161865.

Who is the listed applicant for iSage Rx (iSage Rx Basal Insulin Titration)?

The FDA 510(k) record lists Isag Rx, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for iSage Rx (iSage Rx Basal Insulin Titration)?

The FDA product code for iSage Rx (iSage Rx Basal Insulin Titration) is NDC.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

相关器械(代码:NDC)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑